Lebanon National Drugs Database
This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health
You can search in the form below for information related to drugs including Subsidy percentage
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022
| ATC | Name | B/G | Ingredients | Dosage | Form | Price |
|---|---|---|---|---|---|---|
| L03AX16 | MOZOBIL | B | Plerixafor - 20mg/ml | 20mg/ml | Injectable solution | 413801327.42813 |
| L01FX02 | MYLOTARG | BioTech | Gemtuzumab Ozogamicin - 4.5mg | 4.5mg | Injectable powder | 748160089.81875 |
| L01FX02 | MYLOTARG | BioTech | Gemtuzumab Ozogamicin - 4.5mg | 4.5mg | Injectable powder | |
| L01FG01 | MVASI | BioTech | Bevacizumab - 400mg/16ml | 400mg/16ml | Injectable concentrate for solution | 58035926.487 |
| L01FG01 | MVASI | BioTech | Bevacizumab - 100mg/4ml | 100mg/4ml | Injectable concentrate for solution | 17173671.1272 |
| L01FD01 | MABTIN 440 | BioTech | Trastuzumab (r-DNA origin) - 440mg | 440mg | Injectable powder for solution | 70042700 |
| L01FA01 | MABIXEN 100 | BioTech | Rituximab - 100mg/10ml | 100mg/10ml | Injectable concentrate for solution | 22183392.672 |
| L01FA01 | MABIXEN 100 | BioTech | Rituximab - 100mg/10ml | 100mg/10ml | Injectable concentrate for solution | 11091696.336 |
| L01FA01 | MABTHERA | BioTech | Rituximab - 100mg/10ml | 100mg/10ml | Injectable concentrated solution | 35722423.548 |
| L01FA01 | MABIXEN 500 | BioTech | Rituximab - 500mg/50ml | 500mg/50ml | Injectable concentrate for solution | 136761210.01875 |
| L01FA01 | MABIXEN 500 | BioTech | Rituximab - 500mg/50ml | 500mg/50ml | Injectable concentrate for solution | 74718319.62 |
| L01FA01 | MABTHERA | BioTech | Rituximab - 500mg/50ml | 500mg/50ml | Injectable concentrated solution | 80211931.901719 |
| L01EE03 | MEKTOVI | BioTech | Binimetinib - 15mg | 15mg | Tablet, film coated | 257694409.05797 |
| L01EB02 | MIRATA | G | Erlotinib (HCl) - 100mg | 100mg | Tablet, film coated | 77379008.687251 |
| L01EB02 | MIRATA | G | Erlotinib (HCl) - 150mg | 150mg | Tablet, film coated | 88599922.671483 |
| L01DB07 | MITOXANTRON EBEWE | G | Mitoxantrone - 20mg/10ml | 20mg/10ml | Injectable concentrated solution | 11064119.842125 |
Download the new version of the Ministry of Public Health application and discover new features providing reliable health information
and advanced digital services.
The new version allows you to scan medicine barcodes to verify whether the medication is officially registered with the Ministry of Public Health and distributed through approved official channels, contributing to enhanced patient safety and reducing counterfeit and illegal medicines. In addition to other healthcare services, including:
- Tracking medication records on MediTrack
- Locating the nearest healthcare facility
- Accessing information and statistics on nurseries
- Following the latest health news and updates
The Ministry encourages citizens to rely exclusively on the official application as a trusted source for accurate and reliable health information.
